Literature DB >> 8807584

Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis.

P S Benz1, X Fan, R P Wüthrich.   

Abstract

The cell surface glycoprotein CD44 is expressed by cells of hematopoietic origin and constitutes a receptor for hyaluronic acid and matrix proteins. Because CD44 could play a role in recruiting inflammatory cells to sites of immune injury, we examined the renal CD44 expression in normal and in autoimmune MRL-lpr mice by immunohistochemistry and at a molecular level. In normal kidneys, immunoperoxidase staining for CD44 is restricted to interstitial cells and certain urothelial cells. In nephritic MRL-lpr, CD44 expression is prominent in perivascular inflammatory infiltrates and in glomerular crescents. Interestingly, CD44 is also focally expressed by cortical tubular epithelial cells (TEC) in nephritic MRL-lpr kidneys but not in normal kidneys. Reverse transcription-polymerase chain reaction (RT-PCR) as well as Northern blotting demonstrate that CD44 kidney mRNA levels are increased in nephritic MRL-lpr mice compared with normal mice. To further characterize the tubular CD44 expression, we examined cultured TEC (primary cultures and SV40-transformed TEC lines C1 and MCT). TEC constitutively express abundant cell surface CD44 that is modestly up-regulated in response to 18 hours stimulation with TNF-alpha (100 ng/ml), IFN-gamma (100 U/ml) and IL-1 (100 ng/ml). Northern analysis of TEC mRNA reveals a constitutive CD44 mRNA transcript at 3 kb. Stimulation with IFN-gamma or TNF-alpha for six hours markedly up-regulates CD44 mRNA expression in these cells. We conclude that mononuclear infiltration with CD44 positive cells and cytokine-induced up-regulation of CD44 by renal TEC is a prominent feature of MRL-lpr lupus nephritis. The contribution of CD44 induction on TEC to the pathogenesis of the autoimmune nephritic process in MRL-lpr remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807584     DOI: 10.1038/ki.1996.298

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  T cells and autoimmune kidney disease.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; David Klatzmann; George C Tsokos
Journal:  Nat Rev Nephrol       Date:  2017-03-13       Impact factor: 28.314

2.  Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.

Authors:  K Takazoe; R Foti; G H Tesch; L A Hurst; H Y Lan; R C Atkins; D J Nikolic-Paterson
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

3.  Age associated alterations in costimulatory and adhesion molecule expression in lupus-prone mice are attenuated by food restriction with n-6 and n-3 fatty acids.

Authors:  Alagarraju Muthukumar; Dongxu Sun; Khaliquz Zaman; J L Barnes; David Haile; Gabriel Fernandes
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

4.  Interaction of B7RP-1 with ICOS negatively regulates antigen presentation by B cells.

Authors:  Patricia Wahl; Roland Schoop; Thomas P Horan; Steven K Yoshinaga; Rudolf P Wüthrich
Journal:  Inflammation       Date:  2003-08       Impact factor: 4.092

Review 5.  Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis.

Authors:  Susan Yung; Kwok Fan Cheung; Qing Zhang; Tak Mao Chan
Journal:  Clin Dev Immunol       Date:  2013-09-22

6.  Double negative T cells, a potential biomarker for systemic lupus erythematosus.

Authors:  Jessy J Alexander; Alexander Jacob; Anthony Chang; Richard J Quigg; James N Jarvis
Journal:  Precis Clin Med       Date:  2020-01-20

7.  The Role of Hyaluronan and CD44 in the Pathogenesis of Lupus Nephritis.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Autoimmune Dis       Date:  2012-08-01

Review 8.  Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery.

Authors:  Suniti Misra; Vincent C Hascall; Ilia Atanelishvili; Ricardo Moreno Rodriguez; Roger R Markwald; Shibnath Ghatak
Journal:  Int J Cell Biol       Date:  2015-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.